Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vaccines

Known as: VaccineEntityType, [IM100] VACCINES, vaccine product 
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Review
2014
Review
2014
Vaccine "hesitancy" is an emerging term in the literature and discourse on vaccine decision-making and determinants of vaccine… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
2012
Review
2012
End of study analyses of the phase III trials of prophylactic human papillomavirus (HPV) virus-like particle (VLP) vaccines in… Expand
Review
2010
Review
2010
Adjuvants enhance immunity to vaccines and experimental antigens by a variety of mechanisms. In the past decade, many receptors… Expand
  • table 1
  • figure 1
Review
2009
Review
2009
Over the last decade, there has been a flurry of research on adjuvants for vaccines, and several novel adjuvants are now in… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Review
2007
Review
2007
Influenza continues to have a major worldwide impact, resulting in considerable human suffering and economic burden. The regular… Expand
Highly Cited
2006
Highly Cited
2006
BackgroundVaccine development in the post-genomic era often begins with the in silico screening of genome information, with the… Expand
  • table 1
Review
2005
Review
2005
There is currently great interest in developing mucosal vaccines against a variety of microbial pathogens. Mucosally induced… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
Review
2004
Review
2004
Aluminium adjuvants are the most widely used adjuvants in both human and veterinary vaccines. These adjuvants have been used in… Expand
Review
2002
Review
2002
  • D. Burton
  • Nature Reviews Immunology
  • 2002
  • Corpus ID: 9376285
Neutralizing antibodies are crucial for vaccine-mediated protection against viral diseases. They probably act, in most cases, by… Expand
  • figure 1
  • figure 2
  • figure 3